CEDARS-SINAI MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1902-01-01

Employees: 12K

Market Cap: -

Website: http://www.cedars-sinai.org

Clinical Trials

The Effect of Dexamethasone on the Duration and Functionality of Bupivacaine Intercostal Nerve Blockade

Phase 4

Conditions: Post Minimally Invasive Thorascopic Surgical Pain

Interventions: Drug: Placebo
Drug: Bupivacaine and Dexamethasone

First Posted Date: 2013-12-09

Last Posted Date: 2015-02-04

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 50

Registration Number: NCT02005575

Locations: 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States

Use of FlexHD as Post Trapeziectomy Spacer

Phase 4

Completed

Conditions: Osteoarthrosis of the Carpometacarpal Joint of the Thumb

Interventions: Procedure: Arthroplasty

First Posted Date: 2013-12-02

Last Posted Date: 2019-01-07

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 30

Registration Number: NCT01998594

Locations: 🇺🇸
Cedars-Sinai Department of Hand Surgery, Los Angeles, California, United States

Default BP Medication Intensification

Phase 1

Terminated

Conditions: Hypertension

Interventions: Other: default intensification

First Posted Date: 2013-11-25

Last Posted Date: 2017-02-01

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 3

Registration Number: NCT01994408

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States

Identification of Adverse Plaque Characteristics by Coronary MR Angiography

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Other: Coronary MR Angiography (CMRA)

First Posted Date: 2013-11-19

Last Posted Date: 2021-01-27

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 2

Registration Number: NCT01986868

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States

Prospective Study on Preoperative Versus Postoperative Venous Thromboprophylaxis in Patients Undergoing Major Colorectal Surgery

Phase 3

Completed

Conditions: Venous Thromboembolism

Interventions: Drug: Heparin

First Posted Date: 2013-11-06

Last Posted Date: 2016-10-14

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 410

Registration Number: NCT01976988

Locations: 🇺🇸
Cedars Sinai Medical Center, Los Angeles, California, United States

Efficacy of Propofol or Midazolam Compare to Placebo for Preoperative Medication

Phase 4

Completed

Conditions: Elective Orthopedic Surgery

Interventions: Drug: Propofol
Drug: Midazolam
Drug: Saline

First Posted Date: 2013-11-06

Last Posted Date: 2016-03-14

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 139

Registration Number: NCT01976845

Locations: 🇺🇸
Cedars Sinai Medical center, Los Angeles, California, United States

Efficacy of Popliteal Nerve Blocks With and Without Dexamethasone on the Duration of Analgesia for Foot & Ankle Surgery

Phase 4

Completed

Conditions: Foot and Ankle Procedures

Interventions: Drug: Saline
Drug: Dexamethasone

First Posted Date: 2013-11-03

Last Posted Date: 2016-05-06

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 60

Registration Number: NCT01975285

Locations: 🇺🇸
Cedars Sinai Medical center, Los Angeles, California, United States

Dexmedetomidine for Reversal of Cocaine's Effects on the Heart

Early Phase 1

Completed

Conditions: Chest Pain
Acute Coronary Syndrome

Interventions: Drug: Normal Saline
Drug: Dexmedetomidine
Drug: Intranasal cocaine

First Posted Date: 2013-08-22

Last Posted Date: 2020-01-14

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 115

Registration Number: NCT01927640

Locations: 🇺🇸
Cedars-Sinai, Los Angeles, California, United States

Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery

Not Applicable

Completed

Conditions: Urinary Retention

Interventions: Drug: Prazosin given 6 hours prior to catheter removal in the 24 hour group

First Posted Date: 2013-08-15

Last Posted Date: 2019-02-20

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 142

Registration Number: NCT01923129

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States

Benefit of Elevation of HDL-C in Women

Phase 4

Completed

Conditions: Cardiovascular Outcomes

Interventions: Drug: Placebo
Drug: Niaspan

First Posted Date: 2013-08-13

Last Posted Date: 2019-04-23

Lead Sponsor: Cedars-Sinai Medical Center

Target Recruit Count: 43

Registration Number: NCT01921010

Locations: 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy